Exicure

$2.07
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.01 (-0.48%) Today

+$0.01 (+0.49%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Exicure and other stocks, options, and ETFs commission-free!

About XCUR

Exicure, Inc. Common Stock, also called Exicure, is a clinical-stage biotechnology company, which engages in the discovery, research, and development of treatments based on spherical nucleic acid technology (SNA). It focuses on neurology, immuno-oncology, inflammatory diseases, and other genetic disorders. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in 2011 and is headquartered in Skokie, IL. The listed name for XCUR is Exicure, Inc. Common Stock.

CEO

David A. Giljohann

Employees

—

Headquarters

Chicago, Illinois

Founded

2011

Market Cap

193.58M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

586.00K

High Today

$2.16

Low Today

$1.99

Open Price

$2.13

Volume

877.68K

52 Week High

$3.30

52 Week Low

$0.9573

XCUR Earnings

-$0.12

-$0.08

-$0.03

$0.01

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Mar 8, Pre-Market